Alnylam Pharmaceuticals: Which ETFs hold the stock?
ETFs and index funds whose holdings recorded by us include Alnylam Pharmaceuticals – with weighting and costs. Usually only each fund’s largest holdings are recorded, so the list is not complete. ISIN US02043Q1076
At a glance
Alnylam Pharmaceuticals (ISIN US02043Q1076) is held by 4 of the ETFs and index funds we analyse. The largest weighting is in VanEck Genomics and Healthcare Innovators UCITS ETF A at 3.49%.
Funds holding Alnylam Pharmaceuticals: 4
| Fund | Weight | TER | Details |
|---|---|---|---|
|
VanEck Genomics and Healthcare Innovators UCITS ETF A
IE000B9PQW54
|
3.49%
|
0.35% | Details |
|
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IE00BDZVHG35
|
1.93%
|
0.35% | Details |
|
Invesco Nasdaq Biotech UCITS ETF
IE00BQ70R696
|
1.93%
|
0.40% | Details |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
|
1.93%
|
0.35% | Details |
Analysis tip
A large weighting of a single stock can increase an ETF's volatility. Check how much your overall portfolio depends on individual companies.
Highest weighting
3.49%